FindMyKOL
Clinical trialNCT01329211TerminatedObservational

Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers

NCT01329211 is an observational study sponsored by University of Florida. As of 21 Nov 2026, it was terminated. It studies Gastroparesis. The registry lists an enrollment of 68 participants at 1 site in 1 country. The registry lists a start date of 31 Jan 2010 and a primary completion date of 28 Feb 2013.

SponsorUniversity of Florida →Enrollment68Gastroparesis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01329211
FieldValue
Registry IDNCT01329211
StatusTerminated
Study typeObservational study
Lead sponsorUniversity of Florida
Enrollment68
Registered sites1
Countries1
ConditionsGastroparesis
Start31 Jan 2010
Primary completion28 Feb 2013
Study completion28 Feb 2013
Last update posted20 May 2013

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The project will involve conducting a Needs Assessment for Gastroparesis patients and their caregivers with the goal of identifying quality of life issues associated with this disease. Identifying these issues will ameliorate management and support systems for gastroparesis currently existent in the community and, hopefully, provide information for the establishment of more resources to assist the patients and their families.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Florida, United States1 site
  • University of Florida

    Gainesville

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFlorida: 1 siteFL1District of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01329211

Each answer restates registry values shown on this page.

What is NCT01329211?

NCT01329211 is an observational study sponsored by University of Florida. It studies Gastroparesis.

Who leads NCT01329211?

The registry names Shahnaz Sultan, MD (principal investigator, University of Florida) as the overall official.

Where does NCT01329211 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01329211 end?

The registry lists a primary completion date of 28 Feb 2013 and a study completion date of 28 Feb 2013. The sponsor last updated the record on 20 May 2013.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.